IntegenX, a Pleasanton, California-based developer of Rapid Human DNA identification technology, received a $10M venture loan.
Horizon Technology Finance, Square 1 Bank and a third lender funding their commitments of $3.75m, $2.5m, and $3.75m, respectively.
The company intends to use the funds for working capital purposes.
Led by David V. Smith, Chief Operating Officer, IntegenX develops Rapid human DNA identification technology which integrates advanced fluidics, optics, and biochemistry capabilities to produce products for DNA-based human identity testing for forensics and law enforcement applications.
FinSMEs
24/09/2014